Immunization with the MUC1 vaccine in the murine B16/MUC1+ melanoma model induced greater MUC1-specific CD8+ T cell response compared to HSP70 or deletion of the C-terminal domain alone [56]. The gene discussed is CD8A; the disease is melanoma.